======= MESP2 =======
== Gene Information ==
* **Official Symbol**: MESP2
* **Official Name**: mesoderm posterior bHLH transcription factor 2
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=145873|145873]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q0VG99|Q0VG99]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=MESP2&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20MESP2|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/605195|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: This gene encodes a member of the bHLH family of transcription factors and plays a key role in defining the rostrocaudal patterning of somites via interactions with multiple Notch signaling pathways. This gene is expressed in the anterior presomitic mesoderm and is downregulated immediately after the formation of segmented somites. This gene also plays a role in the formation of epithelial somitic mesoderm and cardiac mesoderm. Mutations in the MESP2 gene cause autosomal recessive spondylocostal dystosis 2 (SCD02). [provided by RefSeq, Oct 2008].
* **UniProt Summary**: Transcription factor with important role in somitogenesis. Defines the rostrocaudal patterning of the somite by participating in distinct Notch pathways. Regulates also the FGF signaling pathway. Specifies the rostral half of the somites. Generates rostro-caudal polarity of somites by down-regulating in the presumptive rostral domain DLL1, a Notch ligand. Participates in the segment border formation by activating in the anterior presomitic mesoderm LFNG, a negative regulator of DLL1-Notch signaling. Acts as a strong suppressor of Notch activity. Together with MESP1 is involved in the epithelialization of somitic mesoderm and in the development of cardiac mesoderm.
|HLH|
|somitogenesis|
|mesoderm formation|
|mesoderm morphogenesis|
|somite development|
|segmentation|
|formation of primary germ layer|
|mesoderm development|
|Notch signaling pathway|
|protein dimerization activity|
|gastrulation|
|anterior/posterior pattern specification|
|heart morphogenesis|
|regionalization|
|pattern specification process|
|RNA polymerase II proximal promoter sequence-specific DNA binding|
|heart development|
|tissue morphogenesis|
|embryonic morphogenesis|
|chordate embryonic development|
|embryo development ending in birth or egg hatching|
|circulatory system development|
|anatomical structure formation involved in morphogenesis|
|animal organ morphogenesis|
|embryo development|
|epithelium development|
|DNA-binding transcription factor activity, RNA polymerase II-specific|
|tissue development|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp24|Nocodazole 0.2μM R00 exp24]]|1.81|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 4303
* **Expression level (log2 read counts)**: -0.48
{{:chemogenomics:nalm6 dist.png?nolink |}}